{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "11407538", "DateCompleted": {"Year": "2001", "Month": "12", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0049-8254", "JournalIssue": {"Volume": "31", "Issue": "2", "PubDate": {"Year": "2001", "Month": "Feb"}}, "Title": "Xenobiotica; the fate of foreign compounds in biological systems", "ISOAbbreviation": "Xenobiotica"}, "ArticleTitle": "Bioactivation to free radicals and cytotoxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b).", "Pagination": {"StartPage": "99", "EndPage": "112", "MedlinePgn": "99-112"}, "Abstract": {"AbstractText": ["1. The in vitro bioactivation by rat liver microsomes and the cytotoxicity in rat hepatocytes of 1,1-dichloro-1-fluoroethane (HCFC-141b), a replacement for some ozone depleting chlorofluorocarbons (CFC), have been investigated. 2. Anaerobic incubations of liver microsomes from pyridine-induced rats with HCFC-141b in the presence of the spin-trapping agent N-t-butyl-alpha-phenylnitrone (PBN) resulted in the formation of a typical ESR radical signal. 3. In the presence of HCFC-141b, a dose-dependent formation of conjugated dienes was observed that was partially inhibited by PBN, glutathione (GSH) and vitamin C. Moreover, HCFC-141b increased the release of lactate dehydrogenase (LDH) and the depletion of cellular glutathione in isolated rat hepatocytes under both normoxic and hypoxic conditions. 4. HCFC-141b-dependent cytotoxicity was completely prevented by PBN under both conditions and it was partially prevented under normoxic conditions by the broad-spectrum P450 inhibitor metyrapone, the P4502E1 specific inhibitor 4-methylpyrazole and the P4503A-specific inhibitor troleandomycin. Interestingly, HCFC-141b-dependent glutathione depletion was not prevented by PBN, metyrapone, 4-methylpyrazole or troleandomycin, whereas two glutathione depletors, 2,6-dimethyl-2,5-heptadien-4-one (phorone) and diethylmaleate, partially prevented LDH release. 5. The present results indicate that HCFC-141b is reductively metabolized in vitro to free radical intermediates by P450, in particular by the CYP2E1 and, to a lower extent, CYP3A isoforms, leading to peroxidative membrane damage and glutathione-independent cytotoxicity."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Medicine & Public Health, University of Padua Medical School, Italy."}], "Identifier": [], "LastName": "Zanovello", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tolando", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ferrara", "ForeName": "R", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bortolato", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Manno", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Xenobiotica", "NlmUniqueID": "1306665", "ISSNLinking": "0049-8254"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chlorofluorocarbons"}, {"RegistryNumber": "0", "NameOfSubstance": "Chlorofluorocarbons, Ethane"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytochrome P-450 Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Free Radicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoenzymes"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "83LCM6L2BY", "NameOfSubstance": "Fomepizole"}, {"RegistryNumber": "9035-51-2", "NameOfSubstance": "Cytochrome P-450 Enzyme System"}, {"RegistryNumber": "C4DZ64560D", "NameOfSubstance": "Troleandomycin"}, {"RegistryNumber": "EC 1.1.1.27", "NameOfSubstance": "L-Lactate Dehydrogenase"}, {"RegistryNumber": "EC 1.14.13.-", "NameOfSubstance": "Cytochrome P-450 CYP2E1"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Aryl Hydrocarbon Hydroxylases"}, {"RegistryNumber": "EC 1.14.14.1", "NameOfSubstance": "Cytochrome P-450 CYP3A"}, {"RegistryNumber": "EC 1.5.-", "NameOfSubstance": "Oxidoreductases, N-Demethylating"}, {"RegistryNumber": "GAN16C9B8O", "NameOfSubstance": "Glutathione"}, {"RegistryNumber": "NH9L3PP67S", "NameOfSubstance": "pyridine"}, {"RegistryNumber": "O1A3ASY5PW", "NameOfSubstance": "1,1-dichloro-1-fluoroethane"}, {"RegistryNumber": "ZS9KD92H6V", "NameOfSubstance": "Metyrapone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Aryl Hydrocarbon Hydroxylases"}, {"QualifierName": ["toxicity"], "DescriptorName": "Chlorofluorocarbons"}, {"QualifierName": [], "DescriptorName": "Chlorofluorocarbons, Ethane"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytochrome P-450 CYP2E1"}, {"QualifierName": [], "DescriptorName": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"QualifierName": [], "DescriptorName": "Cytochrome P-450 CYP3A"}, {"QualifierName": [], "DescriptorName": "Cytochrome P-450 Enzyme Inhibitors"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cytochrome P-450 Enzyme System"}, {"QualifierName": [], "DescriptorName": "Electron Spin Resonance Spectroscopy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Fomepizole"}, {"QualifierName": ["metabolism"], "DescriptorName": "Free Radicals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Glutathione"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Hepatocytes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Isoenzymes"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "L-Lactate Dehydrogenase"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Metyrapone"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Microsomes, Liver"}, {"QualifierName": [], "DescriptorName": "Oxidoreductases, N-Demethylating"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pyrazoles"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pyridines"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Troleandomycin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "6", "Day": "16", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "1", "Day": "5", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "16", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11407538", "10.1080/00498250010031656"]}}], "PubmedBookArticle": []}